Insider Sellers Might Regret Selling Applied Therapeutics Shares at a Lower Price Than Current Market Value
Applied Therapeutics, Inc.’s (NASDAQ:APLT) stock price has dropped 15% in the previous week, but insiders who sold US$8.1m in stock over the past year have had less luck. Insiders would probably have been better off holding on to their shares given that the average selling price of US$5.69 is still lower than the current share price.
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for Applied Therapeutics
Applied Therapeutics Insider Transactions Over The Last Year
The insider, Shoshana Shendelman, made the biggest insider sale in the last 12 months. That single transaction…
